MX390508B - Formulación de isoxazolina tópica localizada que comprende glicofurol. - Google Patents

Formulación de isoxazolina tópica localizada que comprende glicofurol.

Info

Publication number
MX390508B
MX390508B MX2019011837A MX2019011837A MX390508B MX 390508 B MX390508 B MX 390508B MX 2019011837 A MX2019011837 A MX 2019011837A MX 2019011837 A MX2019011837 A MX 2019011837A MX 390508 B MX390508 B MX 390508B
Authority
MX
Mexico
Prior art keywords
glycofurol
formulation including
localized topical
topical isoxazoline
isoxazoline formulation
Prior art date
Application number
MX2019011837A
Other languages
English (en)
Spanish (es)
Other versions
MX2019011837A (es
Inventor
Anja Regina Heckeroth
Hartmut Zoller
Heike Williams
Ramona Müller
Stefan Fuchs
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43920659&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX390508(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2019011837A publication Critical patent/MX2019011837A/es
Publication of MX390508B publication Critical patent/MX390508B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017Non-human animal skin, e.g. pour-on, spot-on
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/14Ectoparasiticides, e.g. scabicides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2019011837A 2010-12-27 2011-12-22 Formulación de isoxazolina tópica localizada que comprende glicofurol. MX390508B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10197090 2010-12-27
US201161430241P 2011-01-06 2011-01-06
PCT/EP2011/073830 WO2012089623A1 (en) 2010-12-27 2011-12-22 Topical localized isoxazoline formulation comprising glycofurol

Publications (2)

Publication Number Publication Date
MX2019011837A MX2019011837A (es) 2019-11-21
MX390508B true MX390508B (es) 2025-03-20

Family

ID=43920659

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2019011837A MX390508B (es) 2010-12-27 2011-12-22 Formulación de isoxazolina tópica localizada que comprende glicofurol.
MX2013007501A MX348079B (es) 2010-12-27 2011-12-22 Formulacion de isoxazolina topica localizada que comprende glucofurol.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2013007501A MX348079B (es) 2010-12-27 2011-12-22 Formulacion de isoxazolina topica localizada que comprende glucofurol.

Country Status (18)

Country Link
US (2) US20130274302A1 (cg-RX-API-DMAC7.html)
EP (1) EP2658541B2 (cg-RX-API-DMAC7.html)
JP (3) JP2014506249A (cg-RX-API-DMAC7.html)
KR (2) KR101992589B1 (cg-RX-API-DMAC7.html)
CN (2) CN103260620A (cg-RX-API-DMAC7.html)
AU (1) AU2011351579B2 (cg-RX-API-DMAC7.html)
BR (1) BR112013015498A2 (cg-RX-API-DMAC7.html)
CA (1) CA2822853C (cg-RX-API-DMAC7.html)
DK (1) DK2658541T3 (cg-RX-API-DMAC7.html)
ES (1) ES2908254T3 (cg-RX-API-DMAC7.html)
HU (1) HUE058290T2 (cg-RX-API-DMAC7.html)
MX (2) MX390508B (cg-RX-API-DMAC7.html)
NZ (1) NZ611474A (cg-RX-API-DMAC7.html)
PL (1) PL2658541T3 (cg-RX-API-DMAC7.html)
PT (1) PT2658541T (cg-RX-API-DMAC7.html)
RU (1) RU2602189C2 (cg-RX-API-DMAC7.html)
WO (1) WO2012089623A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201304515B (cg-RX-API-DMAC7.html)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9173870B2 (en) * 2010-12-27 2015-11-03 Intervet Inc. Topical localized isoxazoline formulation
HUE058290T2 (hu) * 2010-12-27 2022-07-28 Intervet Int Bv Topikális lokalizált izoxazolin formuláció, amely tartalmaz glikofurolt
SG11201400558YA (en) 2011-09-12 2014-04-28 Merial Ltd Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof
TR201909461T4 (tr) 2012-02-06 2019-07-22 Boehringer Ingelheim Animal Health Usa Inc Si̇stemi̇k olarak etki̇ eden akti̇f maddeleri̇ i̇çeren parazi̇ti̇si̇dal oral veteri̇nerli̇ğe ai̇t bi̇leşi̇mler, bunlarin yöntemleri̇ ve kullanimlari
JO3626B1 (ar) 2012-02-23 2020-08-27 Merial Inc تركيبات موضعية تحتوي على فيبرونيل و بيرميثرين و طرق استخدامها
JP6273252B2 (ja) * 2012-03-13 2018-01-31 バイエル・ニュージーランド・リミテッド 長時間作用型の組成物
ES2905848T3 (es) 2013-11-01 2022-04-12 Boehringer Ingelheim Animal Health Usa Inc Compuestos de isoxazolina antiparasitarios y plaguicidas
EP2875726A1 (fr) * 2013-11-13 2015-05-27 Ceva Animal Health Nouvelles applications de compositions vétérinaires dans le traitement contre les parasites
US10272071B2 (en) 2013-12-20 2019-04-30 Intervet Inc. Use of isoxazoline derivatives for the treatment or prevention of arthropod infestations in poultry
CN110327468B (zh) 2013-12-20 2023-04-28 英特维特国际股份有限公司 异噁唑啉组合物及其在预防或治疗动物的寄生虫侵袭中的用途
NZ726251A (en) 2014-04-17 2017-11-24 Merial Inc Use of malononitrile compounds for protecting animals from parasites
FI4008329T3 (fi) 2014-12-22 2025-08-22 Intervet Int Bv Isoksatsoliiniyhdisteitä käytettäväksi hoidettaessa demodikoosia
UY36570A (es) 2015-02-26 2016-10-31 Merial Inc Formulaciones inyectables de acción prolongada que comprenden un agente activo isoxazolina, métodos y usos de las mismas
BR112017021073A2 (pt) 2015-04-08 2018-07-03 Merial Inc composições injetáveis de liberação prolongada compreendendo um agente ativo de isoxazolina, seus métodos e usos
ES2916216T3 (es) 2015-05-20 2022-06-29 Boehringer Ingelheim Animal Health Usa Inc Compuestos de depsipéptidos antihelmínticos
UY37137A (es) 2016-02-24 2017-09-29 Merial Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
CN110381738B (zh) 2016-10-14 2021-07-16 勃林格殷格翰动物保健美国公司 农药的和杀寄生物的乙烯基异噁唑啉化合物
AU2017361099A1 (en) 2016-11-16 2019-06-06 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
CN111194316A (zh) 2017-08-14 2020-05-22 勃林格殷格翰动物保健美国公司 农药的和杀寄生物的吡唑-异噁唑啉化合物
BR112020010291A2 (pt) * 2017-11-23 2020-11-17 Ceva Sante Animale composição contendo moxidectina para tratamento de infestações de parasitas
AR113997A1 (es) 2017-12-21 2020-07-08 Intervet Int Bv Composiciones antiparasitarias para unción dorsal continua
IL279977B2 (en) 2018-07-09 2024-06-01 Boehringer Ingelheim Animal Health Usa Inc Heterocyclic anthelmintic compounds
US11773066B2 (en) 2018-11-20 2023-10-03 Boehringer Ingelheim Animal Health USA Inc. Indazolylcyanoethylamino compound, compositions of same, method of making, and methods of using thereof
JP7637630B2 (ja) 2019-03-19 2025-02-28 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー 駆虫性アザベンゾチオフェンおよびアザベンゾフラン化合物
AU2020268618B2 (en) * 2019-05-03 2025-12-04 Intervet International B.V. Injectable pharmaceutical compositions and uses thereof
AU2020315758B2 (en) 2019-07-16 2024-08-01 Donaghys Limited Transdermal solvent system and methods of use
MX2022007455A (es) 2019-12-18 2022-08-15 Elanco Tiergesundheit Ag Derivados de isoxazolina como plaguicidas.
WO2021242481A1 (en) 2020-05-28 2021-12-02 Boehringer Ingelheim Animal Health USA Inc. Bi-modal release intra-ruminal capsule device and methods of use thereof
CA3183100A1 (en) 2020-05-29 2021-12-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anthelmintic heterocyclic compounds
EP4185585A1 (en) 2020-07-24 2023-05-31 Elanco Us Inc. Process for making an isoxazoline compound and intermediate thereof
US12161089B2 (en) 2020-12-21 2024-12-10 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal collar comprising isoxazoline compounds
US20240116854A1 (en) 2021-01-27 2024-04-11 Intervet Inc. Cyclopropylamide compounds against parasites in fish
BR112023015168A2 (pt) 2021-01-27 2023-10-03 Corteva Agriscience Llc Compostos de ciclopropilamida contra parasitas em peixes
WO2023156938A1 (en) 2022-02-17 2023-08-24 Boehringer Ingelheim Vetmedica Gmbh Method and system for providing a fluid product mailer
NO20240925A1 (en) 2023-09-15 2025-03-17 Evah Atlantic Inc Dihydroisoxazole compound for use in reducing ectoparasite infestations on fish
WO2025191150A2 (en) * 2024-03-15 2025-09-18 Krka, D.D., Novo Mesto Stable isoxazoline formulation for topical application to the skin
WO2025257633A1 (en) 2024-06-12 2025-12-18 Boehringer Ingelheim Vetmedica Gmbh Long-acting castor oil-containing injectable formulations and methods of use thereof

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950360A (en) 1972-06-08 1976-04-13 Sankyo Company Limited Antibiotic substances
US3984564A (en) 1972-06-08 1976-10-05 Sankyo Company Limited Antibiotic substances B-41, their production and their use as insecticides and acaricides
GB8331037D0 (en) * 1983-11-21 1983-12-29 May & Baker Ltd Compositions of matter
US4916154A (en) 1986-09-12 1990-04-10 American Cyanamid Company 23-Imino derivatives of LL-F28249 compounds
IL98599A (en) 1990-06-28 1995-06-29 Merck & Co Inc Stable salts of 4"-deoxy-4"-epi-methylamino avermectin b1a/b1b and insecticidal compositions containing them
US5399717A (en) 1993-09-29 1995-03-21 Merck & Co., Inc. Glycosidation route to 4"-epi-methylamino-4"-deoxyavermectin B1
US20050192319A1 (en) 1996-09-19 2005-09-01 Albert Boeckh Spot-on formulations for combating parasites
US8119150B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
EP1610613B1 (en) * 2003-04-04 2016-12-28 Merial, Inc. Topical anthelmintic veterinary formulations
KR101137785B1 (ko) * 2003-07-18 2012-04-25 백스터 인터내셔널 인코포레이티드 제어된 상 분리에 의해 제조된 작은 구형 입자의 제조방법, 이용 방법 및 조성물
CN102558082B (zh) 2004-03-05 2015-09-30 日产化学工业株式会社 异噁唑啉取代苯甲酰胺化合物的制备中间体
DE102004021281A1 (de) 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
TWI350728B (en) * 2004-10-08 2011-10-21 Wyeth Corp Amitraz compositions
TWI412322B (zh) 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
CA2971008A1 (en) 2007-06-27 2008-12-31 E. I. Du Pont De Nemours And Company Animal pest control method
TWI556741B (zh) * 2007-08-17 2016-11-11 英特威特國際股份有限公司 異唑啉組成物及其作為抗寄生蟲藥上的應用
FR2925337B1 (fr) * 2007-12-21 2010-01-15 Virbac Composition pharmaceutique contenant un derive de n-phenylpyrazole et du glycofurol, utilisation pour la preparation d'un medicament veterinaire topique pour lutter contre les puces
CA2747060A1 (en) 2008-12-18 2010-07-15 Novartis Ag Isoxazolines derivatives and their use as pesticide
AR074790A1 (es) 2008-12-19 2011-02-09 Novartis Ag Derivados de isooxazol sustituidos, composiciones farmaceuticas y para el control de parasitos que los comprenden y su uso en metodos para controlar parasitos en y sobre animales de sangre caliente.
WO2010128095A1 (en) 2009-05-07 2010-11-11 Novartis Ag Ectoparasiticidal compositions
PL3560923T3 (pl) 2009-12-17 2021-12-27 Boehringer Ingelheim Animal Health USA Inc. Dihydroazolowe kompozycje przeciwpasożytnicze i kompozycje je zawierające
DK178277B1 (da) * 2010-06-18 2015-10-26 Novartis Tiergesundheit Ag Diaryloxazolinforbindelser til bekæmpelse af fiskelus
US9173870B2 (en) * 2010-12-27 2015-11-03 Intervet Inc. Topical localized isoxazoline formulation
HUE058290T2 (hu) * 2010-12-27 2022-07-28 Intervet Int Bv Topikális lokalizált izoxazolin formuláció, amely tartalmaz glikofurolt
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments

Also Published As

Publication number Publication date
NZ611474A (en) 2015-08-28
RU2602189C2 (ru) 2016-11-10
US20150011596A1 (en) 2015-01-08
ES2908254T3 (es) 2022-04-28
DK2658541T3 (da) 2022-04-04
RU2013135415A (ru) 2015-02-10
PL2658541T3 (pl) 2022-04-04
EP2658541B1 (en) 2022-01-26
KR20130130762A (ko) 2013-12-02
WO2012089623A1 (en) 2012-07-05
CA2822853A1 (en) 2012-07-05
CA2822853C (en) 2021-05-11
KR101992589B1 (ko) 2019-06-24
KR20180125618A (ko) 2018-11-23
MX2013007501A (es) 2013-08-01
HUE058290T2 (hu) 2022-07-28
EP2658541A1 (en) 2013-11-06
PT2658541T (pt) 2022-03-11
BR112013015498A2 (pt) 2016-11-01
KR101920476B1 (ko) 2018-11-21
AU2011351579B2 (en) 2016-04-21
CN108125951A (zh) 2018-06-08
JP2018154657A (ja) 2018-10-04
EP2658541B2 (en) 2025-12-17
US20130274302A1 (en) 2013-10-17
JP2016216489A (ja) 2016-12-22
ZA201304515B (en) 2014-03-26
MX348079B (es) 2017-05-25
JP2014506249A (ja) 2014-03-13
JP6357508B2 (ja) 2018-07-11
MX2019011837A (es) 2019-11-21
JP6539384B2 (ja) 2019-07-03
CN103260620A (zh) 2013-08-21
AU2011351579A1 (en) 2013-06-20

Similar Documents

Publication Publication Date Title
MX390508B (es) Formulación de isoxazolina tópica localizada que comprende glicofurol.
MX2013007500A (es) Formulacion de isoxazolina topica localizada.
CY2021015I1 (el) Παρασιτοκτονες συνθεσεις οι οποιες περιλαμβανουν εναν δραστικο παραγοντα ισοξαζολινης, μεθοδος και χρησεις αυτων
ATE530170T1 (de) Paliperidonformulierung mit verzögerter freisetzung
UY34264A (es) Compuestos de fórmula genérica 4-(8-metoxi-1-(1-metoxipropan-2-il)-2-(tetrahidro-2H-piran-4-il)-1H- imidazo[4,5-c]quinolin-7-il)-3,5-dimetilisoxazol y sus sales.
EP2874886A4 (en) METHOD FOR PRODUCING FORMABLE EVENT MARKERS WITH A CONSUMABLE INGREDIENT
CO6321189A2 (es) Compuestos de tiazol y oxazol de bencen-sulfonamida
UY34559A (es) Inhibidores de bromodominios
BRPI0913051A2 (pt) sistema ativo de orientação e equilíbrio para um elevador
MA32562B1 (fr) Composes organiques pour la cicatrisation de lesion
CL2008001682A1 (es) Metodos para el mejoramiento de plantas mediante el uso de informacion directa de secuencias de acidos nucleicos.
UY34165A (es) ?compuestos aldh-2 mitocondriales humanos para el tratamiento de la adicción?.
CL2014000450A1 (es) Compuestos derivados de n-(heteroarilmetil)-6-[(2-heteroarilciclopropil)metoxi]pririmidin-4-amina, inhibidores de pde10; composicion farmaceutica; y su uso para el tratamiento de un trastorno seleccionado de trastornos psicóticos, delirantes, entre otros.
IT1398316B1 (it) Struttura di ruota piroettante, particolarmente per mobili e simili.
WO2012106427A3 (en) Methods for treating diabetic foot ulcers
IT1404206B1 (it) Attrezzatura per l'abbacchiatura, particolarmente per l'abbacchiatura di olive e simili
DK2782754T3 (da) Svejsbare oblater til PET.
IT1394226B1 (it) Ruota, in particolare per macchine semoventi quali carrelli o simili, e metodo di realizzazione della stessa.
ECSP10010392A (es) Pirimidil ciclopentanos hidroxilados en forma de inhibidores de akt proteina quinasa
AR086689A1 (es) Auxiliar de la formulacion para la desinfeccion de semillas
UA100850C2 (ru) Средство для борьбы с паразитами на животных
CL2011000722A1 (es) Composicion farmaceutica en forma de unguento estable al almacenamiento, que comprende: a) un compuesto de vitamina d, b) un corticosteroide y c) un compuesto alquilamino sustituido, en un vehiculo de petrolato que opcionalmente contiene aceite mineral, tocoferol o una combinacion de ellos; uso en tratamiento de la psoriasis.
MX2016000116A (es) Formulaciones de compuestos organicos volatiles que tienen actividad antimicrobiana.
EP2472565A4 (en) LUMINESCENT ELEMENT WITH NITRIDE, METHOD OF MANUFACTURING THEREOF, AND LUMINESCENCE METHOD WITH THE ELEMENT
WO2011092604A3 (en) Topical antiparasitic formulations